10x Genomics (TXG) Other financing activities (2019 - 2023)

10x Genomics' Other financing activities history runs 5 years deep, the most recent figure standing at $5.8 million for Q1 2023.

• In Q1 2023, Other financing activities rose 7.49% year-over-year to $5.8 million; the TTM figure through Dec 2023 stood at $5.8 million (up 7.49% YoY), while the FY2023 annual figure was $5.8 million, up 7.49% from the prior year.
• Other financing activities came in at $5.8 million for Q1 2023 at 10x Genomics, up from $5.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $5.8 million in Q1 2020 to a low of -$1.9 million in Q3 2019.
• A 5-year average of $3.2 million and a median of $5.0 million in 2021 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities dropped 13.99% in 2021 and rose 7.58% in 2022, its largest moves.
• 10x Genomics' Other financing activities stood at -$1.9 million in 2019, then soared by 100.1% to $2000.0 in 2020, then soared by 251300.0% to $5.0 million in 2021, then climbed by 7.58% to $5.4 million in 2022, then climbed by 7.49% to $5.8 million in 2023.
• According to Business Quant data, Other financing activities over the past three periods registered $5.8 million, $5.4 million, and $5.0 million for Q1 2023, Q1 2022, and Q1 2021 respectively.

Peer Comparison